-
News | 2023.01.09
Bacterial pathogenicity: improving understanding of an essential process – molecule secretion
Bacteria are not just passive; they are capable of interacting with their close environment. How? One way is by secreting molecules outside their envelope using complex protein machinery. Scientists have recently elucidated the formation mechanisms underpinning one of these secretion systems, thereby paving the way for potential therapeutic applications.
-
News | 2023.01.11
Fake news: author of a misleading video convicted for of public defamation
The Amiens Court of Appeal has upheld the November 2020 judgment of Senlis Criminal Court convicting the author of a misleading video, posted on March 17, 2020, of public defamation against the Institut Pasteur.
-
Document de presse | 2023.01.13
Using paleogenomics to elucidate 10,000 years of immune system evolution
Scientists from the Institut Pasteur, Université Paris Cité, the CNRS and the Collège de France have used paleogenomics to trace 10,000 years of human immune system evolution. They analyzed the genomes of more than 2,800 individuals who lived in Europe over the past ten millennia. They were able to date the increase in frequency of most of the mutations that are advantageous in defending against...
-
Document de presse | 2022.12.13
Epidemics, pandemics: a never-ending story? – a look back at the conference held on December 7, 2022
In connection with the bicentenary of Louis Pasteur’s birth, a conference entitled "Epidemics, pandemics: a never-ending story?" was held on Wednesday December 7 at the Institut Pasteur under the high patronage of the French President, Emmanuel Macron. The conference marked the end of a year of events highlighting not only the importance of research in tackling infectious diseases, but also the...
-
News | 2023.01.18
Signature of a specific agreement between the Institut Pasteur Paris and the Abu Dhabi Public Health Centre to develop training and education programs
The Abu Dhabi Public Health Centre (ADPHC) and the Institut Pasteur have signed a specific agreement to develop training and education programs for Abu Dhabian students, both in Paris and Abu Dhabi.
-
News | 2023.01.18
A journey into the diversity of people with autism
With his book Des gènes, des synapses, des autismes: Un voyage vers la diversité des personnes autistes (French Edition), Thomas Bourgeron and his team delve into DNA in a fascinating investigation in search of the genes associated with autism (or rather the diversity of people with autism).
-
News | 2023.01.06
Development of a pentavalent vaccine against New World arenaviruses
An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses circulating in South America and tested it in a primate model. Each of the viruses has a low incidence but a very high mortality rate, so combining them in a single vaccine would help facilitate vaccine development and ensure that the population can be protected as soon as possible...
-
Document de presse | 2022.12.14
SARS-CoV-2: improving treatment for patients with a severe infection
Inflammatory responses to SARS-CoV-2 vary hugely from one individual to the next. Physicians and scientists from the Institut Pasteur, St. James's Hospital in Dublin and Trinity College Dublin have identified factors of increased vulnerability to COVID-19 in some people, which could guide the development of new therapeutic strategies. In particular, the scientists discovered a link between severe...
-
News | 2023.01.27
Louis Pasteur Bicentenary Prize: five scientists honoured
As we celebrate the bicentenary of Louis Pasteur’s birth, the Institut Pasteur honoured five talented researchers. These prizes, given on January 26, 2023, reward achievements reflecting the “Pasteur ethos” in the fields of biomedical research, public health or innovation. The links between the Carlsberg Foundation and the Institut Pasteur date back to the end of the 19th century
-
News | 2023.01.30
Hepatitis B: towards better treatment for infected individuals in Africa
With 82 million people currently infected in Africa, the hepatitis B virus represents a major health threat. Early treatment can considerably reduce the risk of complications associated with the disease. In a recent analysis, scientists challenged the suitability of the diagnostic tests used in sub-Saharan Africa and called for more optimized treatment for local populations.
